Wells Fargo raises Cencora stock price target to $400 on estimates
Wells Fargo raised its price target for Cencora (NYSE:COR) to $400, citing an 18x multiple on 2028 EPS. The firm adjusted EPS estimates slightly downward for 2027 and 2028. Cencora's Q4 results beat expectations, with EPS of $4.66 and revenue of $88.4B, driven by specialty pharmaceutical demand and acquisitions. The stock trades at a P/E of 19.87 and PEG of 0.16, suggesting potential undervaluation.


